AMGEN 20/50AMGEN 20/50AMGEN 20/50

AMGEN 20/50

No trades
See on Supercharts

Key terms


Outstanding amount
‪1.76 B‬USD
Face value
1,000.00USD
Minimum denomination
2,000.00USD
Coupon
3.38% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
6.26%
Maturity date
Feb 21, 2050
Term to maturity
25 years

About AMGEN 20/50


Sector
Health Technology
Industry
Biotechnology
Home page
Issue date
Feb 21, 2020
FIGI
BBG00RRV3CR3
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.
Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.